Call for Nominations: 2016 Janssen award
Nominations are now being accepted for the 2016 Dr. Paul Janssen Award for Biomedical Research. Every year, the Award celebrates a scientist or group of scientists whose achievements in the field of biomedicine or medical technology have made, or have strong potential to make, a measurable impact on human health. The winner(s) will receive a $200,000 cash prize and broad international recognition for his or her achievements.
The Award was created by Johnson & Johnson in 2004 to honor the memory of Dr. Paul Janssen, widely recognized as one of the most gifted and passionate pharmaceutical researchers of the 20th century, whose work was responsible for breakthrough advancements in several disease areas including pain management, psychiatry, infectious disease and gastroenterology.
Beyond the gifts Dr. Paul demonstrated in the lab, he also devoted much of his time to inspiring and mentoring fellow scientists. I encourage you to take a few moments to recognize an individual—or group—whose work has served as an inspiration to you and has positively impacted the lives of others.
Award nominations will be evaluated by an independent selection committee of renowned researchers from around the world. Past winners have made advancements in diverse areas including genomics, RNA interference, thermosensation, angiogenesis, CRSPR-Cas9 and cancer research.
Nomination forms and more information about the Award may be found at pauljanssenaward.com. Submissions will be accepted until February 29, 2016.
Past Dr. Paul Janssen Award for Biomedical Research Winners and their Innovations…
2006 – Craig Mello, Ph.D. (Nobel Laureate)
Discovery of RNA interference and the elucidation of its biological functions
2008 – Marc Feldmann, FMedSci, FAA and Sir Ravinder Maini, FMedSci, FRCP, FRS
Discovery of tumor necrosis factor-alpha as an effective therapeutic target
for rheumatoid arthritis and other chronic inflammatory conditions
2009 – Axel Ullrich, Ph.D.
Applying molecular biology and molecular cloning to the discovery
of protein therapeutics
2010 – Erik De Clercq, M.D., Ph.D. and Anthony Fauci, M.D.
Understanding and combating viral diseases, particularly HIV/AIDS
2011 – Napoleone Ferrara, M.D.
Research on angiogenesis, the process of new blood vessel formation that plays
a key role in cancer proliferation
2012 – Victor Ambros, Ph.D. and Gary Ruvkun, Ph.D.
Discovery of microRNAs (miRNAs) as central regulators of gene expression
2013 – David Julius, Ph.D.
Discovery of the molecular mechanism that controls thermosensation and elucidation
of the role this mechanism plays in the sensation of acute and inflammatory pain
2014 – Emmanuelle Charpentier, Ph.D. and Jennifer Doudna, Ph.D.
Discovery of a new method for precisely manipulating genetic information
2015 – Bert Vogelstein, M.D.
Discoveries in oncology, which formed the basis of modern cancer research